There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and several have been approved for emergency or full use on six continents. In the US, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Join Us Today for Rutgers Health Policy and Advocacy Corps
- Rutgers-Newark Launches Institute on Improving Communities Through AI and Interdisciplinary Data Work.
- New Jersey Voters Say Finding Quality, Affordable Child Care Is Difficult and a Major Barrier for Working Parents.
- The Hidden Impact of Social Media in the Workplace.
- Measles case confirmed at Newark Liberty International Airport prompts health alert.
Categories
- News (2,797)
- Publication (1)
